Banner & Witcoff, Ltd.
Preparation of and formulation comprising a MEK inhibitor
The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, processes for preparing crystallized 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide, and intermediates useful therefore. Also provided herein are pharmaceutical compositions comprising this crystallized compound.
Array BioPharma Inc.
A C A A A C A C A A C A A A A A A A A C A
A61K C07B A61K A61K A61K C30B A61K C07D A61P A61K C07D A61P A61K A61P A61K A61P A61P A61K A61K C30B A61K
inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Marie-Christine Weidong Christoph Max Marian Werner Heinz Paul Peter J. Daniel Andreas Daniel
Wolf Liu Krell Misun Pachinger Nichols Stengel Niederer Zimmermann